Related Experiment Video
Updated: Jun 20, 2026
07:35
Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
Blinding in clozapine trials: a problem and a potential solution
Tamar Wohlfarth1, Don Linszen, Wim Van Den Brink
1Department of Psychiatry, Academic Medical Center University of Amsterdam, Amsterdam, The Netherlands.
International Journal of Methods in Psychiatric Research
|August 25, 2009
Summary
A new study design addresses a methodological issue in antipsychotic drug trials. This approach maintains blinding and randomization while preventing underestimation of comparator drug efficacy, crucial for clozapine studies.
Area of Science:
- Psychiatry
- Clinical Trials
- Pharmacology
Background:
- Comparing clozapine efficacy with other antipsychotics in double-blind studies presents a methodological challenge.
- Mandatory blood testing for clozapine due to leucopenia/agranulocytosis risks necessitates similar testing in comparator groups to maintain blinding.
- This can lead to underestimation of treatment acceptability and efficacy for comparator drugs.
Purpose of the Study:
- To propose a novel study design to overcome the methodological problem in comparing clozapine with other antipsychotics.
- To preserve randomization and blinding while accurately assessing treatment efficacy and acceptability.
- To minimize the need for blood testing in comparator groups.
Main Methods:
- A thought experiment was conducted to explore solutions for the methodological problem.
- A special study design was developed involving initial randomization to distinct sub-studies.
- One sub-study includes clozapine and a comparator arm; the other includes only comparator arms.
Main Results:
- The proposed design maintains randomization and blinding.
- It prevents the underestimation of comparator treatment effects.
- Blood testing is restricted to a small subset of patients in the clozapine sub-study.
Conclusions:
- The proposed design offers a solution for comparing clozapine with other antipsychotics.
- It addresses similar methodological issues in double-blind studies requiring differential monitoring.
- Limitations of the design are discussed, highlighting its potential applicability to other drug monitoring scenarios (e.g., lithium).
Related Concept Videos
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...